Previously, patients with tumors larger than 4 cm in sub-cardia region usually received open gastrectomy. Due to its anatomic features, the cardia is often considered as a contraindicated area for endoscopic resection. Herein, we report a novel technique of endoscopic submucosal dissection (ESD) which facilitates the removal of gastric subepithelial tumors (SMTs) larger than 4 cm in the subcardia and fundus region. This is a retrospective case series of patients with SMTs larger than 4 cm in the subcardia and fundus regions who received the novel procedure of ESD between October 2015 and October 2016. The novel procedure of ESD involved a median linear incision of the mucosa being made in the central area of the tumor, followed by the submucosal dissection. The residual defect was finally closed using titanium endoclips. The endoscopical outcomes, histopathological findings as well as other complications were assessed. Eight patients fulfilled the entry criteria. The mean lesion size was 45.6±7.5 mm (range: 40.0-65.0 mm), and the mean operating time was 83±13 min (range: 60-100 min). The en bloc resection rate was 100%. Although perforations occurred in 5 out of 8 patients, they were successfully closed with endoclips. The median length of inpatient hospital stay was 6 days (range: 5-8 days). No patients needed further gastrectomy. The median follow-up was 36 months and none of the patients developed local recurrence or distant metastasis. The advanced procedure of ESD is feasible and safe for tumors more than 4 cm in the subcardia region. It could be applied as a novel technique for treating patient without surgical interventions.
Keywords: endoscopic submucosal dissection; gastric subepithelial tumors; subcardia region.
Copyright: © Liu et al.
Feasibility of Endoscopic Submucosal Dissection for Upper Gastrointestinal Submucosal Tumors Treatment and Value of Endoscopic Ultrasonography in Pre-Operation Assess and Post-Operation Follow-Up: A Prospective Study of 224 Cases in a Single Medical CenterG He et al. Surg Endosc 30 (10), 4206-13. PMID 26823060.The predominant SMTs in upper gastrointestinal tract were leiomyoma in esophageal tumors which originated from muscularis mucosae and GIST in stomach which originated fro …
Endoscopic Submucosal Dissection for Foregut Neuroendocrine Tumors: An Initial StudyQL Li et al. World J Gastroenterol 18 (40), 5799-806. PMID 23155323.ESD appears to be a safe, feasible, and effective procedure for providing accurate histopathological evaluations and curative treatment for eligible foregut NETs.
Safety and Efficacy of Endoscopic Submucosal Dissection of Large (≥3 Cm) Subepithelial Tumors Located in the CardiaJ Li et al. Surg Endosc 31 (12), 5183-5191. PMID 28597288.ESD is safe and effective to curatively remove most large SETs in the cardia, and may serve as an accurate histopathology measurement to direct future therapy.
Comparison of Endoscopic Submucosal Dissection and Surgery for the Treatment of Gastric Submucosal Tumors Originating From the Muscularis Propria Layer: A Single-Center Study (With Video)FS Meng et al. Surg Endosc 30 (11), 5099-5107. PMID 27005293.ESD can achieve similar oncological outcomes when compared with surgery for treatment of gastric SMT smaller than 50 mm.
Colorectal Endoscopic Submucosal Dissection: Technical Advantages Compared to Endoscopic Mucosal Resection and Minimally Invasive SurgeryY Saito et al. Dig Endosc 26 Suppl 1, 52-61. PMID 24191896. - ReviewESD is an effective procedure for treating non-invasive non-polypoid colorectal tumors. These tumors may be difficult to resect en bloc by conventional EMR. The use of ES …